Abreu CM, Gama L, Krasemann S et al (2018) Microglia increase inflammatory responses in iPSC-derived human brain spheres. Front Microbiol 9:2766. https://doi.org/10.3389/fmicb.2018.02766
Article
PubMed
PubMed Central
Google Scholar
Alepee N, Bahinski A, Daneshian M et al (2014) State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. Altex 31(4):441–477. https://doi.org/10.14573/altex.1406111
Article
PubMed
PubMed Central
Google Scholar
Almagro JC, Pedraza-Escalona M, Arrieta HI, Perez-Tapia SM (2019) Phage display libraries for antibody therapeutic discovery and development. Antibodies (Basel). https://doi.org/10.3390/antib8030044
Article
Google Scholar
Bailey J, Thew M, Balls M (2014) An analysis of the use of animal models in predicting human toxicology and drug safety. Altern Lab Anim 42(3):181–199. https://doi.org/10.1177/026119291404200306
CAS
Article
PubMed
Google Scholar
Bailey J, Thew M, Balls M (2015) Predicting human drug toxicity and safety via animal tests: can any one species predict drug toxicity in any other, and do monkeys help? Altern Lab Anim 43(6):393–403. https://doi.org/10.1177/026119291504300607
Article
PubMed
Google Scholar
Basketter DA, Clewell H, Kimber I et al (2012) A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. Altex 29(1):3–91. https://doi.org/10.14573/altex.2012.1.003
Article
PubMed
Google Scholar
Beilmann M, Boonen H, Czich A et al (2019) Optimizing drug discovery by investigative toxicology: current and future trends. Altex 36(2):289–313. https://doi.org/10.14573/altex.1808181
Article
PubMed
Google Scholar
Boodman E (2020) Researchers rush to test coronavirus vaccine in people without knowing how well it works in animals. STAT news. https://bit.ly/2xwSDKV. Accessed 26 Apr 2020
Bouhifd M, Andersen ME, Baghdikian C et al (2015) The human toxome project. Altex 32(2):112–124. https://doi.org/10.14573/altex.1502091
Article
PubMed
PubMed Central
Google Scholar
Bruckner T (2020) All COVID-19 clinical trials at a glance. Transparimed. https://bit.ly/2Y2Yumt. Accessed 26 Apr 2020
Busquet F, Kleensang A, Rovida C, Herrmann K, Leist M, Hartung T (2020) New European Union statistics on laboratory animal use—what really counts! Altex 37(2):167–186. https://doi.org/10.14573/altex.2003241
Article
PubMed
Google Scholar
Casadevall A, Pirofski LA (2020) The convalescent sera option for containing COVID-19. J Clin Invest 130(4):1545–1548. https://doi.org/10.1172/JCI138003
CAS
Article
PubMed
Google Scholar
Clark M, Steger-Hartmann T (2018) A big data approach to the concordance of the toxicity of pharmaceuticals in animals and humans. Regul Toxicol Pharmacol 96:94–105. https://doi.org/10.1016/j.yrtph.2018.04.018
CAS
Article
PubMed
Google Scholar
Cohen J (2020) COVID-19 vaccine protects monkeys from new coronavirus, Chinese biotech reports. Sciencemag. https://doi.org/10.1126/science.abc4050
Article
Google Scholar
Collins FS, Gray GM, Bucher JR (2008) Toxicology. Transforming environmental health protection. Science 319(5865):906–907. https://doi.org/10.1126/science.1154619
CAS
Article
PubMed
PubMed Central
Google Scholar
Corvi R, Madia F (2017) In vitro genotoxicity testing—can the performance be enhanced? Food Chem Toxicol 106(Pt B):600–608. https://doi.org/10.1016/j.fct.2016.08.024
CAS
Article
PubMed
Google Scholar
Corvi R, Spielmann H, Hartung T (2019) Alternative approaches for carcinogenicity and reproductive toxicity. In: Balls M, Combes R, Worth A (eds) The history of alternative test methods in toxicology (chapter 3.7). Elsevier Academic Press, London, pp 209–218 (eBook ISBN: 9780128136980, Paperback ISBN: 9780128136973)
Cosson P, Hartley O (2016) Recombinant antibodies for academia: a practical approach. Chim (Aarau) 70(12):893–897. https://doi.org/10.2533/chimia.2016.893
CAS
Article
Google Scholar
Cupedo T, Stroock A, Coles M (2012) Application of tissue engineering to the immune system: development of artificial lymph nodes. Front Immunol 3:343. https://doi.org/10.3389/fimmu.2012.00343
Article
PubMed
PubMed Central
Google Scholar
Daneshian M, Busquet F, Hartung T, Leist M (2015) Animal use for science in Europe. Altex 32(4):261–274. https://doi.org/10.14573/altex.1509081
Article
PubMed
Google Scholar
Daneshian M, Kamp H, Hengstler J, Leist M, van de Water B (2016) Highlight report: launch of a large integrated European in vitro toxicology project: EU-ToxRisk. Arch Toxicol 90(5):1021–1024. https://doi.org/10.1007/s00204-016-1698-7
CAS
Article
PubMed
PubMed Central
Google Scholar
De Mattia F, Chapsal JM, Descamps J et al (2011) The consistency approach for quality control of vaccines—a strategy to improve quality control and implement 3Rs. Biologicals 39(1):59–65. https://doi.org/10.1016/j.biologicals.2010.12.001
CAS
Article
PubMed
Google Scholar
Drake DRI, Singh I, Nguyen MN et al (2012) In vitro biomimetic model of the human immune system for predictive vaccine assessments. Disruptive Sci Technol (Feb). https://doi.org/10.1089/dst.2012.0006
Article
Google Scholar
EC Research and Innovation (2020) Coronavirus: EU mobilises €10 million for research. EC.EUROPA.EU. https://bit.ly/3aEU2Na. Accessed 26 Apr 2020
EMA (2019) Guideline on quality, non-clinical and clinical requirements 5 for investigational advanced therapy medicinal products 6 in clinical trials. EMA/CAT/852602/2018. https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-quality-non-clinical-clinical-requirements-investigational-advanced-therapy_en.pdf. Accessed 26 Apr 2020
EMA (2020a) Update on treatments and vaccines against COVID-19 under development. EMA/160083/2020 media and public relations. https://www.ema.europa.eu/en/news/update-treatments-vaccines-against-covid-19-under-development. Accessed 26 Apr 2020
EMA (2020b) EMA regulatory science to 2025. EMA/110706/2020. https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/ema-regulatory-science-2025-strategic-reflection_en.pdf. Accessed 26 Apr 2020
EPA (2019) Administrator wheeler signs memo to reduce animal testing, awards $4.25 million to advance research on alternative methods to animal testing. EPA news releases. https://bit.ly/2y29ENz. Accessed 26 Apr 2020
Escher SE, Kamp H, Bennekou SH et al (2019) Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project. Arch Toxicol 93(12):3643–3667. https://doi.org/10.1007/s00204-019-02591-7
CAS
Article
PubMed
Google Scholar
Eskes C, Whelan M (2016) Introduction. Adv Exp Med Biol 856:1–7. https://doi.org/10.1007/978-3-319-33826-2_1
CAS
Article
PubMed
Google Scholar
Ewart L, Dehne EM, Fabre K et al (2018) Application of microphysiological systems to enhance safety assessment in drug discovery. Annu Rev Pharmacol Toxicol 58:65–82. https://doi.org/10.1146/annurev-pharmtox-010617-052722
CAS
Article
PubMed
Google Scholar
FDA (2017) FDA’s predictive toxicology roadmap. FDA website. https://bit.ly/3bCU1e4. Accessed 26 Apr 2020
Gao Q, Bao L, Mao H et al (2020) Rapid development of an inactivated vaccine for SARS-CoV-2. Biorxiv. https://doi.org/10.1101/2020.04.17.046375
Article
PubMed
PubMed Central
Google Scholar
Giese C, Marx U (2014) Human immunity in vitro—solving immunogenicity and more. Adv Drug Deliv Rev 69–70:103–122. https://doi.org/10.1016/j.addr.2013.12.011
CAS
Article
PubMed
Google Scholar
Giese C, Demmler CD, Ammer R et al (2006) A human lymph node in vitro–challenges and progress. Artif Organs 30(10):803–808. https://doi.org/10.1111/j.1525-1594.2006.00303.x
CAS
Article
PubMed
Google Scholar
Goh J-Y, Weaver RJ, Dixon L, Platt NJ, Roberts RA (2015) Development and use of in vitro alternatives to animal testing by the pharmaceutical industry 1980–2013. Toxicol Res 4(5):1297–1307. https://doi.org/10.1039/C5TX00123D
CAS
Article
Google Scholar
Gordon S, Daneshian M, Bouwstra J et al (2015) Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology. Altex 32(4):327–378. https://doi.org/10.14573/altex.1510051
Article
PubMed
Google Scholar
Graepel R, Ter Braak B, Escher SE et al (2019) Paradigm shift in safety assessment using new approach methods: the EU-ToxRisk strategy. Curr Opin Pharmacol 15:33–39
Google Scholar
Gray AC, Sidhu SS, Chandrasekera PC, Hendriksen CFM, Borrebaeck CAK (2016) Animal-friendly affinity reagents: replacing the needless in the haystack. Trends Biotechnol 34(12):960–969. https://doi.org/10.1016/j.tibtech.2016.05.017
CAS
Article
PubMed
Google Scholar
Hamm J, Sullivan K, Clippinger AJ et al (2017) Alternative approaches for identifying acute systemic toxicity: moving from research to regulatory testing. Toxicol In Vitro 41:245–259. https://doi.org/10.1016/j.tiv.2017.01.004
CAS
Article
PubMed
PubMed Central
Google Scholar
Hartung T, Leist M (2008) Food for thought … on the evolution of toxicology and the phasing out of animal testing. Altex 25(2):91–102. https://doi.org/10.14573/altex.2008.2.91
Article
PubMed
Google Scholar
Hartung T, Zurlo J (2012) Alternative approaches for medical countermeasures to biological and chemical terrorism and warfare. Altex 29:251–260
Article
Google Scholar
Hernandez LG, van Steeg H, Luijten M, van Benthem J (2009) Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. Mutat Res 682(2–3):94–109. https://doi.org/10.1016/j.mrrev.2009.07.002
CAS
Article
PubMed
Google Scholar
ICH (2020) Detection of reproductive and developmental toxicity for human pharmaceuticals S5 (R3). ICH harmonised guideline. https://bit.ly/3aDR7EH. Accessed 26 Apr 2020
ICMRA (2020) Summary report: global regulatory workshop on COVID-19 vaccine development. IMCRA. https://bit.ly/3bQEOGg. Accessed 26 Apr 2020
IMI (2020) IMI planning EUR 45 million call for proposals on COVID-19. IMI newsroom. https://bit.ly/2YatQaL. Accessed 26 Apr 2020
Jacobs MN, Colacci A, Louekari K et al (2016) International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances. Altex 33(4):359–392. https://doi.org/10.14573/altex.1601201
Article
PubMed
Google Scholar
JHSPH (2020) Infectious disease experts recommend using antibodies from COVID-19 survivors as stopgap measure to treat patients and protect healthcare workers. JHSPH news. https://bit.ly/2Y8con9. Accessed 26 Apr 2020
Kranaster P, Karreman C, Dold J et al (2020) Time and space-resolved quantification of plasma membrane sialylation for measurements of cell function and neurotoxicity. Arch Toxicol 94(2):449–467. https://doi.org/10.1007/s00204-019-02642-z
CAS
Article
PubMed
Google Scholar
Kretzschmar E, Muckenfuss H, Pfleiderer M (2018) Official batch control of influenza vaccines: is it still useful? Vaccine 36(17):2364–2370. https://doi.org/10.1016/j.vaccine.2018.02.078
Article
PubMed
Google Scholar
Krewski D, Acosta D Jr, Andersen M et al (2010) Toxicity testing in the 21st century: a vision and a strategy. J Toxicol Environ Health B Crit Rev 13(2–4):51–138. https://doi.org/10.1080/10937404.2010.483176
CAS
Article
PubMed
PubMed Central
Google Scholar
Krewski D, Andersen M, Tyshenko MG et al (2020) Toxicity testing in the 21st century: progress in the past decade and future perspectives. Arch Toxicol 94:1–58. https://doi.org/10.1007/s00204-019-02613-4
CAS
Article
PubMed
Google Scholar
Le Thanh T, Andreadakis Z, Kumar A et al (2020) The COVID-19 vaccine development landscape. Nat Rev Drug Discov. https://doi.org/10.1038/d41573-020-00073-5
Article
Google Scholar
Leist M, Hartung T (2013) Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice. Arch Toxicol 87(4):563–567. https://doi.org/10.1007/s00204-013-1038-0
CAS
Article
PubMed
PubMed Central
Google Scholar
Leist M, Hartung T, Nicotera P (2008) The dawning of a new age of toxicology. Altex 25(2):103–114
Article
Google Scholar
Leist M, Hasiwa N, Rovida C et al (2014) Consensus report on the future of animal-free systemic toxicity testing. Altex 31(3):341–356. https://doi.org/10.14573/altex.1406091
Article
PubMed
Google Scholar
Marx U, Andersson TB, Bahinski A et al (2016) Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing. Altex 33(3):272–321. https://doi.org/10.14573/altex.1603161
Article
PubMed
PubMed Central
Google Scholar
Marx U, Akabane T, Andersson TB et al (2020) Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development. Altex. https://doi.org/10.14573/altex.2001241
Article
PubMed
Google Scholar
McCray PB Jr, Pewe L, Wohlford-Lenane C et al (2007) Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol 81(2):813–821. https://doi.org/10.1128/JVI.02012-06
CAS
Article
PubMed
Google Scholar
Meigs L, Smirnova L, Rovida C, Leist M, Hartung T (2018) Animal testing and its alternatives—the most important omics is economics. Altex 35(3):275–305. https://doi.org/10.14573/altex.1807041
Article
PubMed
Google Scholar
Monteil V, Kwon H, Prado P et al (2020) Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell J. https://doi.org/10.1016/j.cell.2020.04.004
Article
Google Scholar
Monticello TM, Jones TW, Dambach DM et al (2017) Current nonclinical testing paradigm enables safe entry to First-In-Human clinical trials: the IQ consortium nonclinical to clinical translational database. Toxicol Appl Pharmacol 334:100–109. https://doi.org/10.1016/j.taap.2017.09.006
CAS
Article
PubMed
Google Scholar
Murphy T (2020) Why researchers think HIV meds might work against COVID-19. The body pro. https://bit.ly/354VwPG. Accessed 26 Apr 2020
NAS (2011) Chimpanzees in Biomedical and Behavioral Research: Assessing the Necessity. The National Academies Collection: Reports funded by National Institutes of Health. Institute of Medicine (US) and National Research Council (US) Committee on the Use of Chimpanzees in Biomedical and Behavioral Research, Washington (DC)
Google Scholar
NRC (2007) Toxicity testing in the 21st century: a vision and a strategy. The National Academies Press, Washington, DC. https://doi.org/10.17226/11970
NRC (2011) Animal models for assessing countermeasures to bioterrorism agents. The National Academies Press, Washington, DC. https://doi.org/10.17226/13233
Olson H, Betton G, Robinson D et al (2000) Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 32(1):56–67. https://doi.org/10.1006/rtph.2000.1399
CAS
Article
PubMed
Google Scholar
Park SS (2019) Post-glycosylation modification of sialic acid and its role in virus pathogenesis. Vaccines (Basel). https://doi.org/10.3390/vaccines7040171
Article
PubMed Central
Google Scholar
Parsons LM, Bouwman KM, Azurmendi H, de Vries RP, Cipollo JF, Verheije MH (2019) Glycosylation of the viral attachment protein of avian coronavirus is essential for host cell and receptor binding. J Biol Chem 294(19):7797–7809. https://doi.org/10.1074/jbc.RA119.007532
CAS
Article
PubMed
PubMed Central
Google Scholar
Pinero J, Furlong LI, Sanz F (2018) In silico models in drug development: where we are. Curr Opin Pharmacol 42:111–121. https://doi.org/10.1016/j.coph.2018.08.007
CAS
Article
PubMed
Google Scholar
Roberts M (2020) Coronavirus: US volunteers test first vaccine. BBC news. https://bbc.in/33XZFnY. Accessed 26 Apr 2020
Sanchez-Schmitz G, Stevens CR, Bettencourt IA et al (2018) Microphysiologic human tissue constructs reproduce autologous age-specific BCG and HBV primary immunization in vitro. Front Immunol 9:2634. https://doi.org/10.3389/fimmu.2018.02634
CAS
Article
PubMed
PubMed Central
Google Scholar
Sewell F, Edwards J, Prior H, Robinson S (2016) Opportunities to apply the 3Rs in safety assessment programs. ILAR J 57(2):234–245. https://doi.org/10.1093/ilar/ilw024
CAS
Article
PubMed
PubMed Central
Google Scholar
Siramshetty VB, Nickel J, Omieczynski C, Gohlke BO, Drwal MN, Preissner R (2016) WITHDRAWN—a resource for withdrawn and discontinued drugs. Nucleic Acids Res 44(D1):D1080–D1086. https://doi.org/10.1093/nar/gkv1192
CAS
Article
PubMed
Google Scholar
Strickland J, Clippinger AJ, Brown J et al (2018) Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agencies. Regul Toxicol Pharmacol 94:183–196. https://doi.org/10.1016/j.yrtph.2018.01.022
Article
PubMed
PubMed Central
Google Scholar
Suematsu S, Watanabe T (2004) Generation of a synthetic lymphoid tissue-like organoid in mice. Nat Biotechnol 22(12):1539–1545. https://doi.org/10.1038/nbt1039
CAS
Article
PubMed
Google Scholar
Tamaki C, Nagayama T, Hashiba M et al (2013) Potentials and limitations of nonclinical safety assessment for predicting clinical adverse drug reactions: correlation analysis of 142 approved drugs in Japan. J Toxicol Sci 38(4):581–598. https://doi.org/10.2131/jts.38.581
Article
PubMed
Google Scholar
Thomas RS, Paules RS, Simeonov A et al (2018) The US federal Tox21 program: a strategic and operational plan for continued leadership. Altex 35(2):163–168. https://doi.org/10.14573/altex.1803011
Article
PubMed
PubMed Central
Google Scholar
Tice RR, Austin CP, Kavlock RJ, Bucher JR (2013) Improving the human hazard characterization of chemicals: a Tox21 update. Environ Health Perspect 121(7):756–765. https://doi.org/10.1289/ehp.1205784
CAS
Article
PubMed
PubMed Central
Google Scholar
Tortorici MA, Walls AC, Lang Y et al (2019) Structural basis for human coronavirus attachment to sialic acid receptors. Nat Struct Mol Biol 26(6):481–489. https://doi.org/10.1038/s41594-019-0233-y
CAS
Article
PubMed
PubMed Central
Google Scholar
Vamathevan J, Clark D, Czodrowski P et al (2019) Applications of machine learning in drug discovery and development. Nat Rev Drug Discov 18(6):463–477. https://doi.org/10.1038/s41573-019-0024-5
CAS
Article
PubMed
PubMed Central
Google Scholar
Wheaton S (2020) Von der Leyen hopes for vaccine by ‘autumn,’ defying expert predictions. Politico. https://politi.co/39rIAUR. Accessed 26 Apr 2020
WHO (2003) WHO expert committee on biological standardization: fifty-fourth report. WHO technical report series 927 (ISBN 92 4 120927 5)
Zuang V, Dura A, Asturiol Bofill D, et al (2019) EURL ECVAM status report on the development, validation and regulatory acceptance of alternative methods and approaches. Publications office of the European Union, Luxembourg. https://doi.org/10.2760/25602JRC119292 (ISBN 978-92-76-16368-8)